Story perspectives

New PMRT Guidelines Revolutionize Breast Cancer Treatment Standards

9/18/2025

Summary

Story summary

ASTRO, ASCO, and SSO have updated post-mastectomy radiation therapy (PMRT) guidelines, improving breast cancer treatment standards.
The guidelines recommend PMRT for node-positive patients to lower recurrence risk, while allowing omission in certain low-risk cases.
New radiation techniques, including moderate hypofractionation and intensity-modulated radiation therapy (IMRT), enhance treatment precision and reduce side effects.
Shared decision-making is emphasized to align treatment plans with patient preferences, promoting empowerment and adherence.
The guidelines are based on a comprehensive literature review from 2005 to 2024, supported by major oncology organizations.

1 of 1

Story summary

ASTRO, ASCO, and SSO have updated post-mastectomy radiation therapy (PMRT) guidelines, improving breast cancer treatment standards.
The guidelines recommend PMRT for node-positive patients to lower recurrence risk, while allowing omission in certain low-risk cases.
New radiation techniques, including moderate hypofractionation and intensity-modulated radiation therapy (IMRT), enhance treatment precision and reduce side effects.
Shared decision-making is emphasized to align treatment plans with patient preferences, promoting empowerment and adherence.
The guidelines are based on a comprehensive literature review from 2005 to 2024, supported by major oncology organizations.